Does a preclinical randomized controlled trial, pRCT, resolve the gap between animal studies and human trials?
Related Experiment Video
Updated: Nov 4, 2025

Working with Human Tissues for Translational Cancer Research
Published on: November 26, 2015
Masaomi Nangaku1, Agnes B Fogo2
1Division of Nephrology and Endocrinology, University of Tokyo School of Medicine, Tokyo, Japan.
Abstract:
In drug development, preclinical studies using laboratory animals are crucial to test efficacy and safety of drug candidates. However, there have been discrepancies between animal studies and clinical trials in human patients. Preclinical randomized controlled trials, as reported by Lei et al. in this issue of Kidney International, may reduce the gap between experimental studies and randomized controlled trials in human patients, although there remain issues to be addressed.
More Related Videos
07:59Transition of Farm Pigs to Research Pigs using a Designated Checklist followed by Initiation of Clicker Training - a Refinement Initiative
Published on: August 21, 2021
09:06Quantitative Analysis of Cellular Composition in Advanced Atherosclerotic Lesions of Smooth Muscle Cell Lineage-Tracing Mice
Published on: February 20, 2019
Related Concept Videos
Preclinical Development: Overview
Clinical Trials
There are four phases in a clinical trial. A phase one...
Clinical Trials: Overview
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Mouse Models of Cancer Study
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
Drug Discovery: Overview